by Nicolas Rabener | May 30, 2022 | Uncategorized
Biotech Stocks: High Idiosyncratic Risks, High Alpha? A 30-year recap May 2022. Reading Time: 10 Minutes. Author: Nicolas Rabener. SUMMARYBiotechnology companies have the potential to change our lives dramaticallyHowever, the performance of biotech stocks has been...
by Nicolas Rabener | May 23, 2022 | Uncategorized
Risk Parity & Rising Rates Risky Risk Parity? May 2022. Reading Time: 10 Minutes. Author: Nicolas Rabener. SUMMARYRisk parity strategies have become available via mutual funds and ETFs, but portfolio construction variesRising interest rates are seen as a threat...
by Nicolas Rabener | May 17, 2022 | Uncategorized
Metaverse ETFs: Ready Investor One? Perhaps they are more attractive in XR or VR May 2022. Reading Time: 10 Minutes. Author: Nicolas Rabener. SUMMARY 7 metaverse ETFs have been launched in the last 12 months Despite the hype about the metaverse, these have...
by Nicolas Rabener | May 9, 2022 | Uncategorized
Building a Diversified Portfolio for the Long-Term – Part II This century is unlike the past one for investors May 2022. Reading Time: 10 Minutes. Author: Nicolas Rabener. SUMMARY Most investors have portfolios that are ill-equipped for the long-term Negative...
by Nicolas Rabener | May 2, 2022 | Uncategorized
An Anatomy of Thematic Investing Performance chasing with a narrative May 2022. Reading Time: 10 Minutes. Author: Nicolas Rabener. SUMMARY Thematic investing is combining a good story with positive performance Unfortunately, themes often collapse when the story does...
by Nicolas Rabener | Apr 25, 2022 | Uncategorized
Crypto Tokens and Coins: What Drives Performance? The more popular the token, the higher the price, right? April 2022. Reading Time: 10 Minutes. Author: Nicolas Rabener. SUMMARY Investors assume that token prices increase with product utilization in the token...
